本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MBX Biosciences

61.08
+1.592.67%
盤前61.190.1100+0.18%09:19 EDT
成交量:65.26萬
成交額:3,921.80萬
市值:29.42億
市盈率:-25.39
高:61.20
開:58.79
低:58.39
收:59.49
52周最高:72.64
52周最低:9.64
股本:4,816.01萬
流通股本:2,762.99萬
量比:1.95
換手率:2.36%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
淨資產收益率:-33.17%
總資產收益率:-22.08%
市淨率:7.18
市盈率(LYR):-25.64

資料載入中...

2025/03/17

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/23

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/23

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/20

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/09/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/31

SEC問詢函

Form CORRESP - Correspondence
2024/08/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/27

SEC問詢函

Form CORRESP - Correspondence